MDL 100,907:用于治疗精神分裂症的选择性5-HT2A受体拮抗剂

{"title":"MDL 100,907:用于治疗精神分裂症的选择性5-HT2A受体拮抗剂","authors":"Christopher J. Schmidt, John H. Kehne, Albert A. Carr","doi":"10.1111/j.1527-3458.1997.tb00316.x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94307,"journal":{"name":"CNS drug reviews","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2006-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1527-3458.1997.tb00316.x","citationCount":"15","resultStr":"{\"title\":\"MDL 100,907: A Selective 5-HT2A Receptor Antagonist for the Treatment of Schizophrenia\",\"authors\":\"Christopher J. Schmidt, John H. Kehne, Albert A. Carr\",\"doi\":\"10.1111/j.1527-3458.1997.tb00316.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94307,\"journal\":{\"name\":\"CNS drug reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1527-3458.1997.tb00316.x\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CNS drug reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.1997.tb00316.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS drug reviews","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.1997.tb00316.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}